The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices

Neurovascular disorders are the second most leading causes of death worldwide after heart diseases. Statistical data suggest a high number of people are at an increased risk of developing neurological disorders due to the increasing incidences of lifestyle disorders and aging-related physiological problems in the geriatric populations. The increasing investments and expenditure on neurovascular therapy research and increasing awareness about minimally invasive procedures are boosting the demand for neurovascular devices. Neurovascular devices are based on numerous mechanisms of actions. Neurovascular devices used extensively include embolic coils, flow diversion devices, catheters, arterial stents, guidewires, liquid embolic agents, and others. These devices are often used to treat complex neurovascular disorders and to enhance patient outcomes.

The growth of the neurovascular devices market is majorly driven by the rising number of neurovascular surgeries, the increasing need for minimally invasive procedures, advancements in healthcare infrastructure, and the availability of favorable reimbursement policies. Moreover, the increasing incidences of traumatic brain injury, cerebral aneurysm, and brain stroke are expected to fuel the growth of the market over the coming years. The rising prevalence of the above-mentioned conditions is expected to add traction to the expansion of cerebral embolization and aneurysm coiling devices segment. The advent of advanced therapeutic and diagnostic technology and the benefits and safety offered by microcatheter and microguide wires are further propelling the adoption and growth of the neurovascular devices market. The high prevalence of hypertension, smoking, and increasing initiatives by the government and healthcare facilities to raise awareness is further anticipated to boost the market growth.

Some of the key players operating in the market are W. L. Gore & Associates, Inc., Abbott Laboratories, Terumo Corp., Merit Medical Systems, Inc., Penumbra, Inc., Medtronic Plc, Stryker Corp., MicroPort Scientific Corp., Johnson & Johnson, and others. The prominent players of the industry are focusing on the design and development of innovative neurovascular devices and strategic alliances to gain a substantial footing in the market. In 2019, Medtronic launched ai8 Phenom 21 Catheter, a neurovascular device that dissolves blood clots from the obstructed vessels of the brain to restore the normal circulation of blood in patients with large vessel occlusion. In September 2020, Johnson & Johnson Medical Devices Company’s subsidiary, CERENOVUS launched CERENOVUS Stroke Solutions™ consisting of 3 devices designed to assist the doctors during clot removal procedures.

In July 2020, medical imaging AI specialist, Avicenna, received a clearance from the U.S. FDA for its CINA Head Triage AI solution for neurovascular emergencies. The approval covers the capability of CINA to automatically detect large vessel occlusion and intracranial hemorrhage from images of CT scans.

Read full press release at: https://www.reportsanddata.com/press-release/global-neurovascular-devices-market 

Rising Prevalence of Acute Ischemic Conditions Propels the Acute Ischemia Monitors Market Growth

Acute ischemia is a condition where the blood flow to a particular organ or part of the body is restricted or reduced. Ischemia can typically occur anywhere in the body, and the two significant examples of ischemia are heart attacks and brain strokes. Ischemic stroke is a neurological emergency that can be reversible if treated at the right time. Ischemic heart disease causes the coronary arteries to narrow, restricting blood and oxygen availability to the heart muscles. Sudden restriction in the blood flow causes acute ischemia and is an emergent medical condition. Advancement in the field of heart monitoring devices and their alteration to monitor acute ischemia is driving the adoption of acute ischemia monitors across the globe.

The market is primarily driven by the rising development of the healthcare infrastructure, increasing incidences of acute ischemia, and the technological advancements in heart monitor devices. The advent of insertable monitors and the rising health complications are propelling the adoption of ischemic heart monitors. Moreover, the increasing levels of stress and sedentary lifestyle is increasing the incidences of acute ischemic conditions, which is, in turn, driving the growth of the market. Furthermore, the surge in awareness of acute ischemia complications, as well as other cardiovascular complications, is also anticipated to boost the market growth. With the rising number of cardiovascular surgical interventions and increasing traffic in the emergency room, the adoption of ischemic monitors such as benchtop monitors or portable monitors has witnessed a massive surge. Additionally, favorable reimbursement policies and advancement in the diagnostic techniques are anticipated to bolster the market's growth over the projected timeline.

With rapid advancements in the medical technology and healthcare infrastructure, coupled with soaring medical tourism, the Asia Pacific market is anticipated to expand significantly during the forecast period. The mounting prevalence of acute ischemic conditions is propelling the demand for advanced diagnostic and surgical techniques, thereby driving the market's growth in the region. The rising senior and general population and the emergence of state-of-the-art healthcare infrastructure across India and China contribute to the growth of the market in APAC.

Some of the prominent players of the acute ischemia monitors industry are Alfred Health Victoria Company, Angel Medical Systems Inc., Blue Box Health Inc., Boston Scientific Corp, Cardiowatch Ltd., Flashback Technologies, Inc., Intersection Medical, Inc., Medtronic plc, and Scivanta Medical Corp. In October 2020, Apollo Hospitals Group announced a partnership with India Medtronic, a wholly-owned subsidiary of Medtronic Plc, to incorporate an artificial intelligence platform for ischemic stroke management that will offer an analysis of the stroke in less than two minutes.

Read full press release at: https://www.reportsanddata.com/press-release/global-acute-ischemia-monitors-market

Rising Prevalence of Chronic Liver Conditions and Obesity Boost the Demand for NASH Treatment

Non-alcoholic Steatohepatitis (NASH) is a severe liver inflammation condition and damage caused by fat accumulation in the liver. It is an advanced form of non-alcoholic fatty liver disease (NAFLD), which is a condition that occurs when fatty acids and triglycerides build up in large amounts in the cytoplasm (within the hepatocytes) of non-alcohol users.  NAFLD is caused by the build-up of fat in the liver. Even though NASH does not always progress to its more severe forms, it mostly results in cirrhosis, which is a potentially life-threatening condition leading to scarring of the liver. It can also develop into hepatocellular carcinoma (HCC) – one of the most common forms of liver cancer – at a highly advanced stage of the disease.

The condition is not always symptomatic; however, some of the disease’s common symptoms include fatigue and a (mild) pain in the upper right abdomen. Some of the significant symptoms, such as quick bleeding or bruising, itchy skin, loss of appetite, jaundice, nausea, fluid accumulation in the abdomen, swollen legs, and slurred speech, indicate the gradual progression of the condition to liver cirrhosis. Overweight or obese people are most susceptible to this condition. Other significant causes and risk factors associated with NASH include diabetes, high cholesterol, excessive accumulation of triglycerides, imbalanced diet, metabolic syndrome, sleep apnea, hypothyroidism, and polycystic ovary syndrome. One of the most widely used non-invasive diagnostic procedures for NASH is a liver biopsy. A small piece of tissue is removed from the liver during the liver biopsy for microscopic examination to determine if liver inflammation or scarring has occurred.

The growth of the global Non-alcoholic Steatohepatitis (NASH) market is foreseen to gain momentum in the forthcoming years. Numerous factors, such as the growing adoption of a sedentary lifestyle and the rising prevalence of obesity and diabetes among the populace, are expected to support the global market growth. Several other parameters affecting the market growth include the escalating prevalence of NASH, surging demand for NASH therapeutics, and the potential launch of various pipeline drugs. Vitamin E, Pioglitazone, Elafibranor, Ocaliva, Cenicriviroc, and Selonsertib are the most common types of drugs used globally for the treatment of NASH. Presently, there is no drug or therapeutic for NASH treatment with an FDA clearance. The first-line approach to treating patients with NASH are lifestyle interventions, and Vitamin E and Pioglitazone are among the most recommended drugs.

Allergan plc (Tobira Therapeutics), Conatus Pharmaceuticals Inc., Cadila Healthcare Limited, Gilead Sciences, Inc., Gemphire Therapeutics Inc., Galmed Pharmaceuticals Ltd., Genfit SA, Novartis International AG, Shire Plc, and Intercept Pharmaceuticals, Inc. are the key players operating across the global Non-alcoholic Steatohepatitis (NASH) market. In April 2019, Gilead had announced positive results from its NASH clinical research program at the International Liver Congress 2019. The data supported the company’s efforts to develop specific combination therapies for the disease and helped evaluate the safety and efficacy of the non-invasive tests done for its diagnosis.

Read full press release at: https://www.reportsanddata.com/press-release/global-non-alcoholic-steatohepatitis-nash-market

Hematological Cancers Therapeutics: Immunotherapeutic Strategies to Reimagine Cancer Care

Cancer therapeutics typically involves the administration of anticancer agents such as chemotherapy and oncology drugs for the treatment of cancers. Across the globe, blood malignancies rank as the fifth most prevalent cancer and are the second most cause of death due to cancer. Leukemia, lymphoma, and multiple myeloma are the three most common hematological cancer types, out of which lymphoma is the most common hematological malignancy. Some of the most common therapeutics for hematological cancer are stem cell transplantation, chemotherapy, and radiation therapy. The course of treatment generally depends on the type of cancer, rate of progression, the spread of cancer, and other vital aspects. 

The market growth is being driven by the increasing incidences of hematological cancers and increasing research and development activities to develop new and innovative cancer treatments. Moreover, rising collaborations between pharmaceutical companies and research institutes to design and develop innovative therapeutics for hematological cancers is adding traction to the market. The ongoing research activities by key pharmaceutical companies and research institutions are broadening the horizon of cancer therapies and their mode of action and effectiveness. This is, in turn, driving the growth of the market for hematological cancer therapeutics. Moreover, increasing awareness about various types of blood cancers via blood donation campaigns is playing a pivotal role in early diagnosis and treatment of cancer, thereby propelling the growth of the market. 

Some of the prominent players of the market are F. Hoffman-La Roche, Johnson & Johnson, Siemens AG, AbbVie, Bio-rad Laboratories, Abbott Laboratories, Karyopharm Therapeutics, HemoCue AB, Mindray Medical, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Celgene Corporation, and GlaxoSmithKline, Plc. Over the last few years, the market has witnessed significant mergers and acquisitions and collaborations to develop new and innovative products and therapeutic agents. 

Early diagnosis and high unmet clinical needs of cancer patients drive the companies to develop a new line of chemotherapy drugs and agents. In September 2020, ADC Therapeutics, a Swiss clinical-stage biotechnology company, submitted an application to the drug regulatory board in the U.S. for the approval of commercialization of loncastuximab tesirine as a third-line option for the treatment of Diffuse Large B-cell Lymphoma (DLBCL). In October 2020, Glycostem Therapeutics, a Netherlands-based biotech company, received U.S. FDA’s Orphan Drug Designation for its investigational therapeutic drug, oNKord treatment of multiple myeloma. ONK Therapeutics, a pre-clinical stage company that develops targeted NK-cell therapy for hematological cancers, closed a new round of financing at USD 8 million, which will be used to develop and expand its pre-clinical stage to propel the NK-cell therapy approach to human clinical trials. 

Read full press release at: https://www.reportsanddata.com/press-release/global-hematological-cancers-therapeutics-market

Post-harvest Treatment Market Size & Business Planning, Innovation to See Modest Growth Through 2027

 

The market report study titled ‘Global Post-harvest Treatment Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new projects, financial situations, constructive business strategies, and an outlook on the industry forecast. The report aims to provide an in-depth analysis of the market impacted by the current pandemic. The COID-19 crisis has dynamically changed the economic scenario on a global level. The report is updated with the latest COVID-19 incidence, economic landscape, and present and future impact of COVID-19 on the market.

The research report further studies the growth driving and restraining factors impacting the regional market and competitive landscape of the business sphere. The study also offers deeper insights into the challenges and hurdles the established companies and new entrants might face in the Post-harvest Treatment industry.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2066

Competitive Analysis of the Post-harvest Treatment Market:

The Post-harvest Treatment market is further segmented into key players operating in the Post-harvest Treatment industry. The major companies profiled in the report include Asahi Glass, Interflon, F2 Chemicals Ltd, Halopolymer Kirovo- Deco, Pace International, Xeda International, JBT, Agrofresh, Syngenta, Nufarm, DOW Chemicals, Dupont, Bayer

The Post-harvest Treatment market offers a detailed analysis of the product portfolio, key trends, applications, and a thorough value chain analysis. The report further covers strategic initiatives taken by each player in order to gain a footing in the market and expand their global reach. This includes mergers and acquisitions, product launches, joint ventures, collaborations, government deals, partnerships, and others.

Market Segmentation:

Coating Material (Revenue, USD Million; 2018–2026)

• Coating
• Ethylene Blockers
• Cleaners
• Fungicides
• Sprout Inhibitors
• Sanitizers

Application (Revenue, USD Million; 2018–2026)

• Fruits
• Vegetables

The segmentation section offers pivotal insights into revenue generated as well as volume estimations for each product type and application. The report also offers projections about the product or application segment expected to dominate the market in the coming years. It also highlights the trends of the market and offers a granular assessment of the supply chain.

Regional Analysis:

The report analyzes the market spread across key regions of the world and offers an assessment of the regional market pertaining to the growth rate, sales channels, and revenue generation. Furthermore, the key regions are also assessed for production and consumption rate, import/export, revenue contribution, market share and size, and the market presence of the prominent players in each region.

Key regions analyzed in the report are:

•        North America (U.S., Canada)

•        Europe (U.K., Italy, Germany, France, Rest of EU)

•        Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

•        Latin America (Chile, Brazil, Argentina, Rest of Latin America)

•        Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/post-harvest-treatment-market

Radical Highlights of the Report:

·         Valuable insights about the Global Post-harvest Treatment Market with regards to market size, market share, valuations, and growth rate

·         Provides an 8-year forecast for the years 2020-2027, considering 2017 and 2018 as historical years, 2019 as the base year, and 2027 as the forecast year

·         Extensive analysis of the technological advancements, government regulatory framework, along with recent R&D and product advancements

·         Growth analysis and projections until 2027

·         Statistical analysis of the prominent players of the market

Key Questions Answered by the Report:

·         What are the key driving factors of the Post-harvest Treatment industry?

·         Which segment and sub-segment are expected to show significant growth during the forecast period?

·         What will the market size and growth rate be throughout the forecast period?

·         Who are the prominent players of the Post-harvest Treatment industry?

·         What are the technological advancements and product developments taking place in the Post-harvest Treatment market?

·         Which region is expected to dominate the market in the coming years?

·         What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?

·         What are the key risk factors and challenges the companies will face in the market?

·         What factors are expected to hinder the growth of the Post-harvest Treatment industry

Browse Related Reports –

Thank you for reading our report. The report can be customized based on regional segmentation and leading players. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.

2020 Post-harvest Treatment Market Report Segmented By Competitor, Product Type, Application And Geography | Reports And Data

 

The market report study titled ‘Global Post-harvest Treatment Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new projects, financial situations, constructive business strategies, and an outlook on the industry forecast. The report aims to provide an in-depth analysis of the market impacted by the current pandemic. The COID-19 crisis has dynamically changed the economic scenario on a global level. The report is updated with the latest COVID-19 incidence, economic landscape, and present and future impact of COVID-19 on the market.

The research report further studies the growth driving and restraining factors impacting the regional market and competitive landscape of the business sphere. The study also offers deeper insights into the challenges and hurdles the established companies and new entrants might face in the Post-harvest Treatment industry.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2066

Competitive Analysis of the Post-harvest Treatment Market:

The Post-harvest Treatment market is further segmented into key players operating in the Post-harvest Treatment industry. The major companies profiled in the report include Asahi Glass, Interflon, F2 Chemicals Ltd, Halopolymer Kirovo- Deco, Pace International, Xeda International, JBT, Agrofresh, Syngenta, Nufarm, DOW Chemicals, Dupont, Bayer

The Post-harvest Treatment market offers a detailed analysis of the product portfolio, key trends, applications, and a thorough value chain analysis. The report further covers strategic initiatives taken by each player in order to gain a footing in the market and expand their global reach. This includes mergers and acquisitions, product launches, joint ventures, collaborations, government deals, partnerships, and others.

Market Segmentation:

Coating Material (Revenue, USD Million; 2018–2026)

• Coating
• Ethylene Blockers
• Cleaners
• Fungicides
• Sprout Inhibitors
• Sanitizers

Application (Revenue, USD Million; 2018–2026)

• Fruits
• Vegetables

The segmentation section offers pivotal insights into revenue generated as well as volume estimations for each product type and application. The report also offers projections about the product or application segment expected to dominate the market in the coming years. It also highlights the trends of the market and offers a granular assessment of the supply chain.

Regional Analysis:

The report analyzes the market spread across key regions of the world and offers an assessment of the regional market pertaining to the growth rate, sales channels, and revenue generation. Furthermore, the key regions are also assessed for production and consumption rate, import/export, revenue contribution, market share and size, and the market presence of the prominent players in each region.

Key regions analyzed in the report are:

•        North America (U.S., Canada)

•        Europe (U.K., Italy, Germany, France, Rest of EU)

•        Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

•        Latin America (Chile, Brazil, Argentina, Rest of Latin America)

•        Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/post-harvest-treatment-market

Radical Highlights of the Report:

·         Valuable insights about the Global Post-harvest Treatment Market with regards to market size, market share, valuations, and growth rate

·         Provides an 8-year forecast for the years 2020-2027, considering 2017 and 2018 as historical years, 2019 as the base year, and 2027 as the forecast year

·         Extensive analysis of the technological advancements, government regulatory framework, along with recent R&D and product advancements

·         Growth analysis and projections until 2027

·         Statistical analysis of the prominent players of the market

Key Questions Answered by the Report:

·         What are the key driving factors of the Post-harvest Treatment industry?

·         Which segment and sub-segment are expected to show significant growth during the forecast period?

·         What will the market size and growth rate be throughout the forecast period?

·         Who are the prominent players of the Post-harvest Treatment industry?

·         What are the technological advancements and product developments taking place in the Post-harvest Treatment market?

·         Which region is expected to dominate the market in the coming years?

·         What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?

·         What are the key risk factors and challenges the companies will face in the market?

·         What factors are expected to hinder the growth of the Post-harvest Treatment industry

Browse Related Reports –

Thank you for reading our report. The report can be customized based on regional segmentation and leading players. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.

Engineered Fluids (Fluorinated Fluids) Market Overview with Demographic Data and Industry Growth Trends by 2027

 

The market report study titled ‘Global Engineered Fluids (Fluorinated Fluids) Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new projects, financial situations, constructive business strategies, and an outlook on the industry forecast. The report aims to provide an in-depth analysis of the market impacted by the current pandemic. The COID-19 crisis has dynamically changed the economic scenario on a global level. The report is updated with the latest COVID-19 incidence, economic landscape, and present and future impact of COVID-19 on the market.

The research report further studies the growth driving and restraining factors impacting the regional market and competitive landscape of the business sphere. The study also offers deeper insights into the challenges and hurdles the established companies and new entrants might face in the Engineered Fluids (Fluorinated Fluids) industry.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2056

Competitive Analysis of the Engineered Fluids (Fluorinated Fluids) Market:

The Engineered Fluids (Fluorinated Fluids) market is further segmented into key players operating in the Engineered Fluids (Fluorinated Fluids) industry. The major companies profiled in the report include Asahi Glass, Interflon, F2 Chemicals Ltd, Halopolymer Kirovo-Chepetsk, Solvay, Condat Lubricants, The Chemours Company, Daikin Industries Limited, 3M, Honeywell International Inc., Halocarbon Products Corporation, Klüber Lubrication, Frontier Performance Lubricants, Inc., IKV Tribology, Lubrilog Lubrication Engineering, Nye lubricants, among others. The Engineered Fluids (Fluorinated Fluids) market offers a detailed analysis of the product portfolio, key trends, applications, and a thorough value chain analysis. The report further covers strategic initiatives taken by each player in order to gain a footing in the market and expand their global reach. This includes mergers and acquisitions, product launches, joint ventures, collaborations, government deals, partnerships, and others.

Market Segmentation:

Polymer Outlook (Volume, Kilo Tons and Revenue, USD Billion; 2016-2026)

• Polytetrafluoroethylene (PTFE)
• Polyvinyl Fluoride (PVF)
• Polyvinylidene Fluoride (PVDF)
• Others

Product Type Outlook (Volume, Kilo Tons and Revenue, USD Billion; 2016-2026)

• Heat Transfer Liquids
• Lubricants
• Solvents

Industry Vertical Outlook (Volume, Kilo Tons and Revenue, USD Billion; 2016-2026)

• Electronics & Semiconductor
• Aerospace
• Chemical Processing
• Automotive
• Oil & Gas
• Others

The segmentation section offers pivotal insights into revenue generated as well as volume estimations for each product type and application. The report also offers projections about the product or application segment expected to dominate the market in the coming years. It also highlights the trends of the market and offers a granular assessment of the supply chain.

Regional Analysis:

The report analyzes the market spread across key regions of the world and offers an assessment of the regional market pertaining to the growth rate, sales channels, and revenue generation. Furthermore, the key regions are also assessed for production and consumption rate, import/export, revenue contribution, market share and size, and the market presence of the prominent players in each region.

Key regions analyzed in the report are:

•        North America (U.S., Canada)

•        Europe (U.K., Italy, Germany, France, Rest of EU)

•        Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

•        Latin America (Chile, Brazil, Argentina, Rest of Latin America)

•        Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/engineered-fluids-fluorinated-fluids-market

Radical Highlights of the Report:

·         Valuable insights about the Global Engineered Fluids (Fluorinated Fluids) Market with regards to market size, market share, valuations, and growth rate

·         Provides an 8-year forecast for the years 2020-2027, considering 2017 and 2018 as historical years, 2019 as the base year, and 2027 as the forecast year

·         Extensive analysis of the technological advancements, government regulatory framework, along with recent R&D and product advancements

·         Growth analysis and projections until 2027

·         Statistical analysis of the prominent players of the market

Key Questions Answered by the Report:

·         What are the key driving factors of the Engineered Fluids (Fluorinated Fluids) industry?

·         Which segment and sub-segment are expected to show significant growth during the forecast period?

·         What will the market size and growth rate be throughout the forecast period?

·         Who are the prominent players of the Engineered Fluids (Fluorinated Fluids) industry?

·         What are the technological advancements and product developments taking place in the Engineered Fluids (Fluorinated Fluids) market?

·         Which region is expected to dominate the market in the coming years?

·         What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?

·         What are the key risk factors and challenges the companies will face in the market?

·         What factors are expected to hinder the growth of the Engineered Fluids (Fluorinated Fluids) industry

Browse Related Reports –

Thank you for reading our report. The report can be customized based on regional segmentation and leading players. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.

Engineered Fluids (Fluorinated Fluids) Market 2020, Engineered Fluids (Fluorinated Fluids) Market size, Engineered Fluids (Fluorinated Fluids) Market share, Engineered Fluids (Fluorinated Fluids) Market trends, Engineered Fluids (Fluorinated Fluids) Market growth, Engineered Fluids (Fluorinated Fluids) Market demand, Engineered Fluids (Fluorinated Fluids) Market Analysis, Engineered Fluids (Fluorinated Fluids) Market Forecast, Engineered Fluids (Fluorinated Fluids) Market research